Capricor Therapeutics
CAPR
#7990
Rank
HK$2.26 B
Marketcap
HK$49.47
Share price
-4.36%
Change (1 day)
-57.20%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$0.33 Billion

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are HK$0.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.19 B-31.17%
2023-12-31HK$0.28 B-5.72%
2022-12-31HK$0.29 B285.31%
2021-12-31HK$77.68 M56.11%
2020-12-31HK$49.76 M49.49%
2019-12-31HK$33.28 M-8.22%
2018-12-31HK$36.26 M-8.02%
2017-12-31HK$39.43 M-77.65%
2016-12-31HK$0.17 B33.1%
2015-12-31HK$0.13 B-14.04%
2014-12-31HK$0.15 B227.46%
2013-12-31HK$47.09 M1048.08%
2012-12-31HK$4.1 M-2.47%
2011-12-31HK$4.2 M-49.45%
2010-12-31HK$8.31 M68.3%
2009-12-31HK$4.94 M-51.97%
2008-12-31HK$10.29 M-30.14%
2007-12-31HK$14.73 M1305.37%
2006-12-31HK$1.04 M73.54%
2005-12-31HK$0.6 M30.86%
2004-12-31HK$0.46 M42.59%
2003-12-31HK$0.32 M69.06%
2002-12-31HK$0.19 M167.36%
2001-12-31HK$0.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
HK$15.22 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$78.68 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.19 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$9.81 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.38 B 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$20.24 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA